ACADIA PHARMACEUTICALS INC Quarterly Operating Lease, Payments in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Acadia Pharmaceuticals Inc quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q2 2024.
  • Acadia Pharmaceuticals Inc Operating Lease, Payments for the quarter ending June 30, 2024 was $2.68M, a 14% increase year-over-year.
  • Acadia Pharmaceuticals Inc Operating Lease, Payments for the twelve months ending June 30, 2024 was $9.82M, a 5.26% increase year-over-year.
  • Acadia Pharmaceuticals Inc annual Operating Lease, Payments for 2023 was $9.46M, a 4.11% increase from 2022.
  • Acadia Pharmaceuticals Inc annual Operating Lease, Payments for 2022 was $9.08M, a 71.3% increase from 2021.
  • Acadia Pharmaceuticals Inc annual Operating Lease, Payments for 2021 was $5.3M, a 18.4% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $9.82M $2.68M +$328K +14% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $9.49M $2.41M +$35K +1.48% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $9.46M $2.39M +$80K +3.46% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $9.38M $2.34M +$48K +2.09% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $9.33M $2.35M +$65K +2.85% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $9.26M $2.37M +$180K +8.22% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $9.08M $2.31M +$434K +23.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $8.65M $2.29M +$581K +33.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $8.07M $2.29M +$1.59M +228% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $6.48M $2.19M +$1.18M +116% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $5.3M $1.88M +$1.11M +144% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $4.19M $1.71M +$585K +51.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $3.61M $696K -$595K -46.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $4.2M $1.01M -$277K -21.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $4.48M $770K -$501K -39.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $4.98M $1.13M -$112K -9.03% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $5.09M $1.29M +$63K +5.13% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $5.03M $1.29M +$189K +17.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $4.84M $1.27M Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $1.24M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $1.23M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.1M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.